Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IL-6 | 100 | ug/mL | 2 | VEGF | 643.0 | 81 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 599.0 | 45 | |
RA2159 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 410.0 | 57 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 401.5 | 58 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 498.0 | 56 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 444.0 | 58 | |
RA2159 | Ruxolitinib | 0.3 | uM | 2 | VEGF | 608.5 | 52 | ||||
N2586 | IL-6 | 100 | ug/mL | 2 | VEGF | 1036.0 | 63 | ||||
N2586 | EO1428 | 1.0 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 629.0 | 59 | |
N2586 | PI103 | 0.1 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 1008.5 | 60 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 1004.5 | 46 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 864.0 | 59 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-6 | 100 | ug/mL | 2 | VEGF | 812.5 | 44 | |
N2586 | Ruxolitinib | 0.3 | uM | 2 | VEGF | 1085.5 | 50 | ||||
RA2159 | IL-17A | 100 | ng/mL | 2 | VEGF | 679.0 | 69 | ||||
RA2159 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 645.0 | 73 | |
RA2159 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 430.0 | 67 | |
RA2159 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 626.0 | 50 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 553.0 | 47 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 882.0 | 43 | |
RA2159 | Tofacitinib | 0.3 | uM | 2 | VEGF | 455.0 | 53 | ||||
N2586 | IL-17A | 100 | ng/mL | 2 | VEGF | 1304.0 | 55 | ||||
N2586 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 1075.0 | 63 | |
N2586 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 460.0 | 59 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 2 | VEGF | 953.0 | 72 |